Filter posts

Protecting your IP Overseas

According to the World Intellectual Property Organization (WIPO), nearly 100,000 biotechnology and pharmaceutical patent applications …

Patent Parameters

Supreme Court Finds Naturally Occurring DNA to Be Patent Ineligible Last summer, the Supreme Court …

Supreme Court Enunciates New Indefiniteness Standard

The Supreme Court has once again reversed a decision by the Federal Circuit, in this …

What OxyContin Tells Us About the Value of “Evergreening" and Patents

A few weeks ago, the  FDA announced that they would not allow generic versions of …

How to Survive the Patent Cliff: Eli Lilly’s CEO at the BIO CEO & Investor Conference

Like a number of companies, Eli Lilly is confronting a wave of patent expirations called …

Seed Patents: How Innovation May Get Lost in the Grain Elevator

The Bowman v. Monsanto case currently on petition for a writ of certiorari to the …

Prior User Rights and Trade Secrets

By Joe Allen, President, Allen and Associates One theme of the day is the cloud …

Celebrating 30 Years of Biotechnology Innovation: From Diamond v. Chakrabarty to Today

David Kappos, Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent …

USTR: TPP to have High IP Standards to "Stand Alongside other Treaty Agreements in the Area"

Stan McCoy, Assisant U.S. Trade Representative for Intellectual Property and Innovation, spoke at BIO’s 2011 …

Patents in the U.S. Supreme Court

A special session at the 2011 BIO International Convention takes a fascinating look at the …